Conflict of interest statement: H.K.R. has received consulting fees from AstraZeneca, GlaxoSmithKline, Novartis and Biota; speaking fees from AstraZeneca, GlaxoSmithKline, Merck and Getz; and grant support from GlaxoSmithKline and AstraZeneca. None of the other authors have any conflict of interest to declare.
Year-in-review 2009: Asthma, COPD and airway biology
Article first published online: 26 JAN 2010
© 2010 The Authors. Journal compilation © 2010 Asian Pacific Society of Respirology
Volume 15, Issue 2, pages 365–376, February 2010
How to Cite
REDDEL, H. K., UPHAM, J. W., SALVI, S. S. and YANG, I. A. (2010), Year-in-review 2009: Asthma, COPD and airway biology. Respirology, 15: 365–376. doi: 10.1111/j.1440-1843.2009.01702.x
- Issue published online: 26 JAN 2010
- Article first published online: 26 JAN 2010
- Received 4 December 2009; accepted 6 December 2009.